Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Copper
Drug ID BADD_D00529
Description Copper is a transition metal and a trace element in the body. It is important to the function of many enzymes including cytochrome c oxidase, monoamine oxidase and superoxide dismutase [FDA Label]. Copper is commonly used in contraceptive intrauterine devices (IUD) [L801].
Indications and Usage For use in the supplementation of total parenteral nutrition and in contraception with intrauterine devices [FDA Label] [L801].
Marketing Status approved; investigational
ATC Code Not Available
DrugBank ID DB09130
KEGG ID Not Available
MeSH ID D003300
PubChem ID 23978
TTD Drug ID D01WMJ
NDC Product Code 68428-349; 82815-0001; 62106-5020; 51285-204; 0220-1623; 0220-1635; 59365-5128; 68428-140; 64117-958; 0220-1636
UNII 789U1901C5
Synonyms Copper | Copper-63 | Copper 63
Chemical Information
Molecular Formula Cu
CAS Registry Number 7440-50-8
SMILES [Cu]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Perforation08.01.03.058--Not Available
Complication associated with device08.07.01.011-Not Available
Cervical cyst21.06.02.006; 16.04.05.002-Not Available
Colonic fistula07.11.05.007-
Grief reaction19.23.01.003-Not Available
Hydrosalpinx21.11.02.015-Not Available
Normal newborn18.08.06.001-Not Available
Ovarian cyst ruptured21.11.01.015; 16.04.03.006-Not Available
Pelvic adhesions21.07.04.009; 07.07.03.005-Not Available
Post abortion haemorrhage24.07.03.027; 18.01.03.004-Not Available
Post-traumatic stress disorder19.06.06.002-Not Available
Uterine tenderness21.07.01.022-Not Available
Ruptured ectopic pregnancy18.02.02.005-Not Available
Live birth18.08.02.007-Not Available
Phlebolith24.03.02.029-Not Available
Uterine cervical pain21.06.01.014-Not Available
Deformity08.01.03.022-Not Available
Uterine haematoma24.07.03.031; 21.07.01.018-Not Available
Pelvic fluid collection21.07.04.011; 07.07.01.009-Not Available
Allergy to metals10.01.03.042-Not Available
Skin plaque23.03.03.044-Not Available
Uterine cervix stenosis21.06.01.015-Not Available
Cervix inflammation21.14.05.003-Not Available
Subchorionic haemorrhage24.07.03.030; 18.02.01.007-Not Available
Uterine adhesions21.07.01.016; 12.02.14.007-Not Available
Uterine scar12.02.14.008; 21.07.01.020-Not Available
Procedural anxiety12.02.04.011; 19.06.02.010-Not Available
Abnormal uterine bleeding21.01.01.013-Not Available
Administration site indentation23.03.03.071; 12.07.04.021; 08.02.04.021-Not Available
Cervix scarring21.06.01.018; 18.07.04.007; 12.01.15.010-Not Available
The 5th Page    First    Pre   5 6    Next   Last    Total 6 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene